Tokyo, March 31 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061080) titled 'Effects of collagen tripeptide supplementation combined with resistance training on Achilles tendon and calf muscle properties' on March 30.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Non-randomized Blinding - Double blind -all involved are blinded Control - Placebo

Primary Sponsor: Institute - Nippon Sport Science University

Condition: Condition - Achilles tendinopathy Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To investigate the effects of collagen tripeptide supplementation combined with resistance training on the morphological and functional properties of the Achilles tendon and triceps surae. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - Collagen tripeptide supplementation

Participants will ingest collagen tripeptide (product name: HACP-BV50) orally once daily at a dose of 2 g (one packet) for a period of 14 weeks.

Each packet (2 g) contains 7 kcal of energy, 1.8 g of protein, 0 g of fat, 0 g of carbohydrates, and 0.03 g of salt equivalent. The total collagen content is 1800 mg, including 810 mg of tripeptides. The product is manufactured in Japan. Interventions/Control_2 - maltodextrin supplementation

Participants will ingest maltodextrin orally once daily at a dose of 2 g (one packet) for a period of 14 weeks.

This intervention will be administered as a placebo and will be matched to the collagen tripeptide supplementation in terms of administration method and frequency.

Each packet (2 g) contains approximately 8 kcal of energy, 0 g of protein, 0 g of fat, approximately 2 g of carbohydrates, and 0 g of salt equivalent.

Eligibility: Age-lower limit - 18 years-old = Gender - Male Key inclusion criteria - Healthy young males with no regular exercise habits, a body mass index (BMI) between 18.5 and 25.0 Key exclusion criteria - history of lower extremity musculoskeletal injuries Target Size - 24

Recruitment Status: Recruitment status - No longer recruiting Date of protocol fixation - 2025 Year 01 Month 01 Day Date of IRB - 2023 Year 10 Month 11 Day Anticipated trial start date - 2025 Year 01 Month 01 Day Last follow-up date - 2026 Year 04 Month 30 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069890

Disclaimer: Curated by HT Syndication.